Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The ...
New Delhi, Sep 15 (PTI) Aurobindo Pharma on Tuesday said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Please provide your email address to receive an email when new articles are posted on . Inhalation parameters recorded by a digital asthma device can be used to indicate inhaler technique ...
Please provide your email address to receive an email when new articles are posted on . Asmacure announced that combined phase 1 and 2a study results of a novel mechanism of action in a dry powder for ...
hands holding a smart phone How effective are add-on devices for pressurized metered-dose inhalers in helping patients with asthma to avoid poor outcomes associated with incorrect inhaler use? In ...
AEROSPAN (flunisolide HFA) 80mcg inhalation aerosol by Acton Pharmaceuticals Acton Pharmaceuticals announced that the FDA has approved the sNDA (Supplemental New Drug Application) for Aerospan ...
Asthma is a common chronic respiratory disease that leads to difficulty breathing due to the presence of inflammation and bronchoconstriction. It’s often triggered by allergens, irritants or ...
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Inhaler device errors are common and may impact the effectiveness of the delivered drug. There is a paucity of up-to-date systematic reviews (SRs) or meta-analyses (MAs) of device errors in asthma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results